Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06476171 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Validation of Hematological Indices

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 25, 2024 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Nov 1, 2024 to Nov 1, 2025
    • Study completion date: Dec 30, 2024 to Dec 30, 2025
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The hypothesis of the study is that hematological indices (neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and systemic index of inflammation) may be predictors of infectious complications and multiple organ dysfunction in patients after cardiac surgery.
Trial Details
NCT Number NCT06476171
Lead Sponsor Petrovsky National Research Centre of Surgery
Conditions
(from sponsor)		 Multiple Organ Dysfunction, Sepsis, Pneumonia, Wound Infection
Related terms Pneumonia, Sepsis, Wound Infection
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov